Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Liver Cancer 2018 NCI 5R01CA202245-03 Biological roles and Mediator-dependent transcription mechanisms of RNA polymerase II(G) ROEDER, ROBERT ROCKEFELLER UNIVERSITY NY $387,731
Liver Cancer 2018 NCI 5R01CA184456-03 VDAC Regulation of Warburg Metabolism in Hepatocarcinoma MALDONADO, EDUARDO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $341,981
Liver Cancer 2018 NCI 5P30CA014089-43 8293 Gastrointestinal Cancers Research Program (Project-006) KAHN, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $70,375
Liver Cancer 2018 NCI 5R01CA175380-05 FoxM1 in liver cancer. RAYCHAUDHURI, PRADIP UNIVERSITY OF ILLINOIS AT CHICAGO IL $405,146
Liver Cancer 2018 NCI 5R01CA204996-02 Determining Unique Metabolic features of Hepatocellular Carcinoma. LU, ZHIMIN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $366,000
Liver Cancer 2018 NCI 5R01CA181658-04 MRI-Monitored Delivery of Sorafenib-Eluting Microspheres to Liver Tumors LARSON, ANDREW NORTHWESTERN UNIVERSITY AT CHICAGO IL $451,626
Liver Cancer 2018 NCI 5R01CA204446-02 Antivascular ultrasound therapy of primary liver neoplasia SEHGAL, CHANDRA UNIVERSITY OF PENNSYLVANIA PA $415,179
Liver Cancer 2018 NCI 5R03CA212877-02 Tumor Molecular Profiling and Response to Immunotherapy in Advanced Biliary Cancers KELLEY, R. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Cancer 2018 NIAAA 5P50AA011999-20 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $203,571
Liver Cancer 2018 NCI 5P30CA015704-43 5445 Research Program: Gastrointestinal Cancer GRADY, WILLIAM FRED HUTCHINSON CANCER RESEARCH CENTER WA $86,922
Liver Cancer 2018 NCI 5R01CA139158-07 MiRNAs in hepatocellular carcinoma development and treatment HUANG, WENDONG BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $410,875
Liver Cancer 2018 NCI 5R01CA102325-12 15-PGDH in Cholangiocarcinogenesis WU, TONG TULANE UNIVERSITY OF LOUISIANA LA $344,269
Liver Cancer 2018 NCI 5R01CA190844-04 Hepatic Stellate Cells and Liver Cancer SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $356,751
Liver Cancer 2018 NCI 5R01CA193244-08 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $365,750
Liver Cancer 2018 NIBIB 5R01EB022148-03 Cancer-specific nanoparticle-mediated gene therapy to treat hepatocellular carcinoma GREEN, JORDAN JOHNS HOPKINS UNIVERSITY MD $364,500
Liver Cancer 2018 NIGMS 1P20GM121316-01A1 8787 Spartan Protease Repairs DNA-Protein Cross-Links (DPCs) and Prevents DPC-Induced Oncogenesis GHOSAL, GARGI UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $278,465
Liver Cancer 2018 NIA 5R01AG016927-20 The Role of Akt in Cell Survival and Cell Growth HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $455,327
Liver Cancer 2018 NCI 5R01CA190776-04 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $546,636
Liver Cancer 2018 NCI 2P01CA013106-46A1 5083 Project 2: Regulation of Pre-mRNA Splicing in Tumorigenesis KRAINER, ADRIAN COLD SPRING HARBOR LABORATORY NY $666,200
Liver Cancer 2018 NCI 2P01CA013106-46A1 5086 Project 5: Tumor Suppressor and Tumor Maintenance Genes LOWE, SCOTT SLOAN-KETTERING INST CAN RESEARCH NY $632,982
Liver Cancer 2018 NCI 1P50CA210964-01A1 5541 Core A: Administrative Core MC NIVEN, MARK MAYO CLINIC ROCHESTER MN $292,321
Liver Cancer 2018 NCI 1P50CA210964-01A1 5542 Core B: Biostatistics / Bioinformatics MANDREKAR, SUMITHRA MAYO CLINIC ROCHESTER MN $83,953
Liver Cancer 2018 NCI 1P50CA210964-01A1 5543 Core C: Biospecimen and Pathology Core TORBENSON, MICHAEL MAYO CLINIC ROCHESTER MN $377,264
Liver Cancer 2018 NCI 1P50CA210964-01A1 5544 Project 1: Fibrolamellar HCC TORBENSON, MICHAEL MAYO CLINIC ROCHESTER MN $373,625
Liver Cancer 2018 NCI 1P50CA210964-01A1 5545 Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial GORES, GREGORY MAYO CLINIC ROCHESTER MN $359,336
Liver Cancer 2018 NCI 1P50CA210964-01A1 5546 Project 3: Inhibition of SCD1 as a therapeutic strategy for HCC ALBERTS, STEVEN MAYO CLINIC ROCHESTER MN $315,636
Liver Cancer 2018 NCI 1P50CA210964-01A1 5547 Project 4: Immunovirotherapy VILE, RICHARD MAYO CLINIC ROCHESTER MN $321,665
Liver Cancer 2018 NCI 1P50CA210964-01A1 5548 Developmental Research Program LEOF, EDWARD MAYO CLINIC ROCHESTER MN $88,100
Liver Cancer 2018 NCI 1P50CA210964-01A1 5549 Career Enhancement Program ROBERTS, LEWIS MAYO CLINIC ROCHESTER MN $88,100
Liver Cancer 2018 NCI 1R01CA222900-01 Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis SINGAL, AMIT UT SOUTHWESTERN MEDICAL CENTER TX $562,950
Liver Cancer 2018 NCI 1R01CA222490-01 Liver Cancer Therapy by MiR-22 and Its Inducers WAN, YU-JUI UNIVERSITY OF CALIFORNIA AT DAVIS CA $395,120
Liver Cancer 2018 NCI 1R01CA222570-01 Serotonergic antidepressants as liver tumor preventives EVASON, KIMBERLEY UNIVERSITY OF UTAH UT $347,510
Liver Cancer 2018 NCI 1R01CA222571-01 Cellular and molecular mechanism of Hippo signaling in suppressing liver tumor formation YANG, YINGZI HARVARD MEDICAL SCHOOL MA $387,731
Liver Cancer 2018 NCI 1R01CA222649-01 FGFR4 intracellular domain promotes tumor progression in cholangiocarcinoma MOTT, JUSTIN UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $346,973
Liver Cancer 2018 NCI 5R01CA172086-05 PROHIBITIN 1 IN LIVER INJURY AND CANCER LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $312,404
Liver Cancer 2018 NHLBI 1K22HL139921-01 Identification and Characterization of Novel Metabolic Regulators in Mouse and Human Liver YANG, LING TEMPLE UNIV OF THE COMMONWEALTH PA $248,999
Liver Cancer 2018 NIAID 5R01AI120622-02 RESUBMISSION -R01 AI120622 –Restoration of Immunity and Function with DAA Treatment in HCV infection ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $43,343
Liver Cancer 2018 NIDDK 5R01DK074932-12 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Liver Cancer 2018 NCI 5R01CA211794-02 Role of p62/SQSTM1 in obesity-induced liver cancer KARIN, MICHAEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $726,246
Liver Cancer 2018 NCI 5R01CA086978-15 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Liver Cancer 2018 NCI 5R01CA168912-05 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI AUGUSTA UNIVERSITY GA $320,588
Liver Cancer 2018 NCI 5R01CA200310-03 Functions of BNIP3 in lipid metabolism in the liver and in hepatocellular carcinoma MACLEOD, KAY UNIVERSITY OF CHICAGO IL $397,573
Liver Cancer 2018 NCI 5R01CA176012-05 Molecular and cellular communications in liver tumorigenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $321,625
Liver Cancer 2018 NIDDK 5R01DK102667-04 Innovative Genetic Approaches for Hepatic Repopulation KAESTNER, KLAUS UNIVERSITY OF PENNSYLVANIA PA $360,000
Liver Cancer 2018 NCI 5R01CA204586-03 Yap and beta-catenin interactions in liver: Implications in Pathophysiology MONGA, SATDARSHAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $416,268
Liver Cancer 2018 NCI 5R01CA080946-18 Selenoproteins as targets for cancer prevention GLADYSHEV, VADIM BRIGHAM AND WOMEN'S HOSPITAL MA $223,000
Liver Cancer 2018 NCI 5K99CA215315-02 Regulation of tumor growth and metabolism by hyperinsulinemia PERRY, RACHEL YALE UNIVERSITY CT $148,502
Liver Cancer 2018 NCI 5R00CA191152-04 Development of mosaic mouse models of HCC for genetic interspecies inference FONT-BURGADA, JOAN RESEARCH INST OF FOX CHASE CAN CTR PA $249,000
Liver Cancer 2018 NCI 2R01CA176647-06 Mutant p53 as actionable cancer-specific target MOLL, UTE STATE UNIVERSITY NEW YORK STONY BROOK NY $382,587
Liver Cancer 2018 NCI 5R01CA185169-05 Targeting Acetyl-CoA Metabolism for the Discovery of New Anti-Cancer Therapeutics MCKNIGHT, STEVEN UT SOUTHWESTERN MEDICAL CENTER TX $475,351
Liver Cancer 2018 NCI 5R01CA200597-03 HMGB1 as Link Between Hepatocellular Injury and HCC SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $443,761
Liver Cancer 2018 NCI 5U01CA202934-02 Optical and electromagnetic tracking guidance for hepatic interventions MAHMOOD, UMAR MASSACHUSETTS GENERAL HOSPITAL MA $379,411
Liver Cancer 2018 NCI 5R01CA194307-03 2D and 3D Contrast-enhanced Ultrasound Evaluation of HCC Chemoembolization EISENBREY, JOHN THOMAS JEFFERSON UNIVERSITY PA $105,860
Liver Cancer 2018 NCI 1R01CA213419-01A1 Interplay of bile acid and estrogen signaling DENG, RUITANG UNIVERSITY OF RHODE ISLAND RI $344,755
Liver Cancer 2018 NCI 5R00CA190783-04 Mass Spectrometry Imaging for Clinical Diagnosis and Prognosis of Human Cancers SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN TX $235,946
Liver Cancer 2018 NIDDK 5R01DK113645-02 Hepatitis C virus infection and mechanism of liver disease progression RAY, RANJIT SAINT LOUIS UNIVERSITY MO $340,875
Liver Cancer 2018 NCI 1R01CA215651-01A1 Dual PI3K/BRD4 inhibitory chemotype for maximum inhibition of Myc and cancer DURDEN, DONALD UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $509,469
Liver Cancer 2018 NCI 5R01CA211602-02 Large aperture and wideband modular ultrasound arrays for the diagnosis of liver cancer FERRARA, KATHERINE UNIVERSITY OF CALIFORNIA AT DAVIS CA $144,998
Liver Cancer 2018 NCI 5F31CA216994-02 Elucidating the role of cell-specific Wnts in hepatocellular carcinoma PREZIOSI, MORGAN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $8,693
Liver Cancer 2018 NIDDK 5R01DK104956-04 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $532,832
Liver Cancer 2018 NCI 5R01CA190606-03 Signaling cascades in cholangiocarcinoma development CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $362,569
Liver Cancer 2018 NCI 5R01CA090764-17 P13K/PTEN/Akt signaling and the genesis of cancer HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $425,203
Liver Cancer 2018 NIAAA 1R21AA025470-01A1 LncRNA with MSI2 and super-enhancer in liver cancer stem cells induced by alcohol MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $209,210
Liver Cancer 2018 NCI 5R01CA186566-04 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $620,205
Liver Cancer 2018 NCI 5R01CA190144-04 Liver Cancer Risk with rAAV Gene Therapy GROMPE, MARKUS OREGON HEALTH & SCIENCE UNIVERSITY OR $586,035
Liver Cancer 2018 NCI 5R03CA208311-02 Inducible systems for studying liver tumor mainenance in vivo CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Cancer 2018 NCI 1R01CA211217-01A1 Novel, Noninvasive, Rapid Tumor Ablation Technology using Histotripsy XU, ZHEN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $514,797
Liver Cancer 2018 NIDDK 5R01DK108743-03 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $433,352
Liver Cancer 2018 NCI 5P30CA086862-18 7670 Program 1: Cancer Genes and Pathways QUELLE, DAWN UNIVERSITY OF IOWA IA $19,504
Liver Cancer 2018 NCI 5R01CA209888-02 Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery PAULMURUGAN, RAMASAMY STANFORD UNIVERSITY CA $640,842
Liver Cancer 2018 NCI 5R01CA188305-04 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $338,033
Liver Cancer 2018 NIGMS 5P20GM113226-03 6174 High fat diet induced hepatocyte exosomes-promoted hepatic inflammation and tumorigenesis DENG, ZHONG-BIN UNIVERSITY OF LOUISVILLE KY $152,683
Liver Cancer 2018 NIDDK 5R01DK106395-03 Metabolic imaging of nonalcoholic fatty liver disease MAYER, DIRK UNIVERSITY OF MARYLAND BALTIMORE MD $448,705
Liver Cancer 2018 NCI 5R01CA121275-10 Tumor suppressor roles of E2F7 & E2F8 in hepatocellular carcinoma LEONE, GUSTAVO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $295,681
Liver Cancer 2018 NCI 1F30CA216947-01A1 Investigating the Relationship Between Racial Residential Segregation and Hepatocellular Carcinoma BEMANIAN, AMIN MEDICAL COLLEGE OF WISCONSIN WI $49,524
Liver Cancer 2018 NCI 1F32CA224985-01 Antibody-fucosidase conjugates as therapy for hepatocellular carcinoma PEH, JESSIE STANFORD UNIVERSITY CA $58,282
Liver Cancer 2018 NCI 1F30CA225058-01 Exploiting Metabolic Changes in HCC for Cancer Therapy TERRY, ALEXANDER UNIVERSITY OF ILLINOIS AT CHICAGO IL $49,524
Liver Cancer 2018 NCI 1F32CA225145-01 Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma SINGER, ZAKARY COLUMBIA UNIV NEW YORK MORNINGSIDE NY $59,038
Liver Cancer 2018 NIDDK 5R01DK090311-08 Estrogen Regulation of Hepatic Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $629,907
Liver Cancer 2018 NIAAA 5K08AA025112-03 Stearoyl-CoA Desaturase in Alcohol-Promoted Liver Tumorigenesis LAI, KEANE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $195,588
Liver Cancer 2018 NIGMS 5R01GM118122-18 Metabolism of Carcinogens and Drugs by Human P450s GUENGERICH, F VANDERBILT UNIVERSITY TN $368,951
Liver Cancer 2018 NIDDK 1R01DK116620-01 TAZ and YAP in Non-Alcoholic Steatohepatitis and its Complications TABAS, IRA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $664,138
Liver Cancer 2018 NIDDK 5R01DK044533-20 Mechanisms of Hepatocyte Transformation by the Hepatitis B Virus X Protein ANDRISANI, OURANIA PURDUE UNIVERSITY IN $346,173
Liver Cancer 2018 NCI 5R01CA195524-03 Early Detection of Hepatocellular Carcinoma BERETTA, LAURA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $644,934
Liver Cancer 2018 NCI 5R01CA190525-04 Reactivation of embryonic growth programs in liver cancer ZHU, HAO UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Liver Cancer 2018 NCI 5R01CA174735-05 The role of MDM2-MTBP axis in cancer metastasis IWAKUMA, TOMOO UNIVERSITY OF KANSAS MEDICAL CENTER KS $313,325
Liver Cancer 2018 NCI 5R01CA194574-04 Enhancing Liver Cancer Treatment With Image-Guided Magnetic Hyperthermia LIAPI, ELENI JOHNS HOPKINS UNIVERSITY MD $638,541
Liver Cancer 2018 NCI 5R01CA198103-03 ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $668,490
Liver Cancer 2018 NCI 5P01CA203628-03 7232 Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression BRITTEN, CAROLYN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $521,898
Liver Cancer 2018 NCI 5U54CA193417-04 7363 Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology: Administrative Core DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $363,348
Liver Cancer 2018 NCI 5U54CA193417-04 7364 Core 1: Cell and Tissue Core WELLS, REBECCA UNIVERSITY OF PENNSYLVANIA PA $263,761
Liver Cancer 2018 NCI 5U54CA193417-04 7365 Core 2: Theory Core - Multiscale models for mechano-chemical phenomena LIU, ANDREA UNIVERSITY OF PENNSYLVANIA PA $263,761
Liver Cancer 2018 NCI 5U54CA193417-04 7366 Project 1: Mechanisms of Stiffening in Liver Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $331,048
Liver Cancer 2018 NCI 5U54CA193417-04 7367 Project 2: Physical Mechanisms and Clinical Implications of Mechano-transduction RADHAKRISHNAN, RAVI UNIVERSITY OF PENNSYLVANIA PA $305,963
Liver Cancer 2018 NCI 5U54CA193417-04 7368 Project 3: Nuclear Rheology & Stability in Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $318,506
Liver Cancer 2018 NCI 5U54CA193417-04 7369 PSOC@Penn Education and Outreach DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $134,573
Liver Cancer 2018 NCI 5R01CA181566-04 Compact Representations of Dynamic Liver MRI SPINCEMAILLE, PASCAL WEILL MEDICAL COLL OF CORNELL UNIV NY $387,731
Liver Cancer 2018 NCI 5UG3CA211551-02 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $403,427
Liver Cancer 2018 NCI 5R01CA190678-04 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $337,795
Liver Cancer 2018 NCI 5P01CA087497-17 5245 Core C - The Molecular Systems Pathology Core CORDON-CARDO, CARLOS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $247,698
Liver Cancer 2018 NCI 5R21CA209940-02 Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma POCHET, NATHALIE BRIGHAM AND WOMEN'S HOSPITAL MA $175,001
Liver Cancer 2018 NCI 5R01CA178063-05 Role of beta-catenin in apoptosis resistance of hepatocellular carcinoma RANA, BASABI UNIVERSITY OF ILLINOIS AT CHICAGO IL $331,793
Liver Cancer 2018 NCI 5R01CA202769-03 Development of cell-free DNA assays for HCC screening and liquid biopsy SU, YING-HSIU BARUCH S. BLUMBERG INSTITUTE PA $397,877
Liver Cancer 2018 NCI 5R01CA194533-04 Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity HETTS, STEVEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $515,286
Liver Cancer 2018 NCI 5R01CA203985-03 Mechanism of Met-Induced Hepatocyte Survival ZARNEGAR, REZA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $352,275
Liver Cancer 2018 NIMHD 1R01MD012565-01 Multilevel factors for racial/ethnic and socioeconomic disparities in prognosis of hepatocellular carcinoma SINGAL, AMIT UT SOUTHWESTERN MEDICAL CENTER TX $805,897
Liver Cancer 2018 NCI 1R01CA228589-01 Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations SETIAWAN, VERONICA UNIVERSITY OF SOUTHERN CALIFORNIA CA $601,819
Liver Cancer 2018 NCI 1R21CA225623-01 Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $176,514
Liver Cancer 2018 NIDDK 5F32DK109651-03 Mechanisms of differential susceptibility to nonalcoholic fatty liver disease RIORDAN, JESSE PACIFIC NORTHWEST RESEARCH INSTITUTE WA $7,933
Liver Cancer 2018 NCI 5R01CA051497-28 Myc - Transcription and Apoptosis DANG, CHI WISTAR INSTITUTE PA $382,892
Liver Cancer 2018 NCI 5P01CA059827-20 5908 Response-driven Treatment of Hepatocellular Carcinoma LAWRENCE, THEODORE UNIVERSITY OF MICHIGAN MI $342,669
Liver Cancer 2018 NCI 5R42CA183376-03 Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis YANG, JENNY INLIGHTA BIOSCIENCES, LLC GA $728,995
Liver Cancer 2018 NCI 5R01CA206465-03 (PQ4)HIV and Aging Mechanisms for Hepatocellular Cancer JUSTICE, AMY YALE UNIVERSITY CT $512,833
Liver Cancer 2018 NCI 1U01CA212007-01A1 Integrating bioinformatics into multiscale models for hepatocellular carcinoma FERTIG, ELANA JOHNS HOPKINS UNIVERSITY MD $607,918
Liver Cancer 2018 NIBIB 5R01EB022075-03 Imaging and Dosimetry of Yttrium-90 for Personalized Cancer Treatment DEWARAJA, YUNI UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $459,820
Liver Cancer 2018 NCI 5UG3CA211232-02 Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer CHILKOTI, ASHUTOSH DUKE UNIVERSITY NC $385,158
Liver Cancer 2018 NIEHS 5R01ES025909-04 Molecular Basis of Cancer Cell Metabolic Reprogramming WANG, LI UNIVERSITY OF CONNECTICUT STORRS CT $355,500
Liver Cancer 2018 NCI 1U01CA225753-01 Screening of Glycan Markers in Serum for Early Detection of HCC in Different Etiologies of Disease LUBMAN, DAVID UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $529,478
Liver Cancer 2018 NCI 1R01CA227289-01 Precise image guidance for liver cancer stereotactic body radiotherapy using element-resolved motion-compensated cone beam CT JIA, XUN UT SOUTHWESTERN MEDICAL CENTER TX $407,275
Liver Cancer 2018 NCCIH 5R01AT001576-16 Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $294,016
Liver Cancer 2018 NCI 5R01CA215702-02 Image Guided Delivery and Evaluation of Low? Density Lipoprotein-Docosahexaenoic acid Nanoparticles for the Management of Hepatocellular Carcinoma CORBIN, IAN UT SOUTHWESTERN MEDICAL CENTER TX $370,575
Liver Cancer 2018 NIDDK 5R01DK107288-04 S-Adenosylmethionine in Protein Posttranslational Modifications and HCC Treatment LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $402,939
Liver Cancer 2018 NCI 1R01CA204665-01A1 Genomics of HCC in the Hispanic population of Texas BERETTA, LAURA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $390,463
Liver Cancer 2018 NCI 5R01CA208396-02 Combination of ceramide and immunotherapy in treatment of hepatocellular cancer STAVELEY-O'CARROLL, KEVIN UNIVERSITY OF MISSOURI-COLUMBIA MO $545,802
Liver Cancer 2018 NIDDK 5K01DK106346-04 Altered endosomal protein sorting in the pathogenesis of hepatocellular carcinoma SINGLA, AMIKA UT SOUTHWESTERN MEDICAL CENTER TX $124,040
Liver Cancer 2018 NCI 1R21CA216807-01A1 Analysis of HCC CTC Phenotype for Liver Transplant Candidate Selection AGOPIAN, VATCHE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $203,254
Liver Cancer 2018 NIAAA 5F32AA025271-03 The role of mechanical signaling in alcoholic liver disease and hepatocellular carcinoma WRIGHTON, PAUL BRIGHAM AND WOMEN'S HOSPITAL MA $61,174
Liver Cancer 2018 NCI 5R01CA183764-04 The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle GRADILONE, SERGIO UNIVERSITY OF MINNESOTA MN $348,844
Liver Cancer 2018 NCI 5R01CA219144-03 Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma VIJAY-KUMAR, MATAM UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $289,344
Liver Cancer 2018 NCI 5R01CA188506-04 Dissection of Pten-regulated signals in hepatopathogenesis FENG, GEN-SHENG UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $404,404
Liver Cancer 2018 NCI 5R01CA204145-03 Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $260,399
Liver Cancer 2018 NCI 5R01CA206167-03 Hexokinase 2 in liver cancer HAY, NISSIM UNIVERSITY OF ILLINOIS AT CHICAGO IL $440,113
Liver Cancer 2018 NCI 5R01CA196692-04 Does Screening for HCC in Cirrhotic Patients Reduce HCC-related Mortality? IOANNOU, GEORGE SEATTLE INST FOR BIOMEDICAL/CLINICAL RES WA $273,336
Liver Cancer 2018 NCI 5K08CA194268-05 Novel targeted therapies for isocitrate dehydrogenase mutantcholangiocarcinoma SAHA, SUPRIYA FRED HUTCHINSON CANCER RESEARCH CENTER WA $169,020
Liver Cancer 2018 NCI 5R01CA197128-04 Molecular mechanisms of focal adhesion kinase in promoting hepatocarcinogenesis QIU, WEI LOYOLA UNIVERSITY CHICAGO IL $345,493
Liver Cancer 2018 NCI 5R01CA160254-07 Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach LUBMAN, DAVID UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $360,861
Liver Cancer 2018 NCI 5R01CA201127-03 Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology CRESSMAN, ERIK UNIVERSITY OF TX MD ANDERSON CAN CTR TX $365,719
Liver Cancer 2018 NCI 1R21CA215883-01A1 Assessment of gene expression profiles related to hepatocellular carcinoma in HCV: singlecell hepatocyte sequencing as a tool to identify cancer-related genes DEBES, JOSE UNIVERSITY OF MINNESOTA MN $167,385
Liver Cancer 2018 NCI 5R01CA080024-21 Intra and Extra-Chromosomal Probes for Mutagenesis by Carcinogens ESSIGMANN, JOHN MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $374,208
Liver Cancer 2018 NIDDK 5R01DK107451-03 The role of AEG-1 in NASH and NASH-HCC SARKAR, DEVANAND VIRGINIA COMMONWEALTH UNIVERSITY VA $342,853
Liver Cancer 2018 NCI 5R03CA208215-02 SWI/SNF complex in mouse HCC development CHEN, XIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $79,250
Liver Cancer 2018 NCI 5F31CA210639-03 Improving Sorafenib; a multi-targeted kinase inhibitor used for the treatment of hepatocellular carcinoma by mechanistically dissecting out its underlying targets and anti-targets YU, JIA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $41,724
Liver Cancer 2018 NCI 1R01CA216254-01A1 (PQ5) Relevance of VDAC2 heterogeneity for hepatic tumor growth and targeting HAJNOCZKY, GYORGY THOMAS JEFFERSON UNIVERSITY PA $413,916
Liver Cancer 2018 NCI 5R01CA196967-04 MRI-Guided Irreversible Electroporation Ablation for Liver Tumors ZHANG, ZHUOLI NORTHWESTERN UNIVERSITY AT CHICAGO IL $347,209
Liver Cancer 2018 NCI 5R01CA203565-04 Nutritional Control of Cancer Cell Function by Amino Acids KILBERG, MICHAEL UNIVERSITY OF FLORIDA FL $343,125
Liver Cancer 2018 NIEHS 5P42ES010337-17 5193 Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells KARIN, MICHAEL UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $348,011
Liver Cancer 2018 NIEHS 5P42ES010337-17 5195 Project 3: Molecular and Microbial Mechanisms Leading to Triclosan Induced Liver Fibrosis TUKEY, ROBERT UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $298,012
Liver Cancer 2018 NIEHS 5P42ES010337-17 5946 Core-005: Training Core MELLON, PAMELA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $120,771
Liver Cancer 2018 NIGMS 5P20GM103457-10 8295 Project 3: Linking maternal obesity and offspring cancer risks through integrati GARMIRE, LANA UNIVERSITY OF HAWAII AT MANOA HI $266,445
Liver Cancer 2018 NCI 1R01CA217833-01A1 Extracellular vesicle RNA signaling in liver tumor microenvironment PATEL, TUSHAR MAYO CLINIC JACKSONVILLE FL $357,994
Liver Cancer 2018 NIAAA 5U01AA022614-05 The Role of IL-17 in Alcoholic Liver Disease and Cancer KISSELEVA, TATIANA UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $353,250
Liver Cancer 2018 NIDDK 1R01DK114131-01A1 Protein inclusions in non-alcoholic steatohepatitis LEE, JUN HEE UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $345,960
Liver Cancer 2018 NCI 1R01CA218659-01A1 Catheter-Directed Image-Guided Delivery of Cytostatic and Cytotoxic Combination Therapy to Liver Tumors KIM, DONG-HYUN NORTHWESTERN UNIVERSITY AT CHICAGO IL $352,824
Liver Cancer 2018 NCI 5R01CA206180-03 Quantitative Multimodal Image Guidance for Improved Liver Cancer Treatment DUNCAN, JAMES YALE UNIVERSITY CT $634,276
Liver Cancer 2018 NCI 2R01CA164719-06A1 Targeting parasite-host communication to combat liver fluke-induced bile duct cancer BRINDLEY, PAUL GEORGE WASHINGTON UNIVERSITY DC $673,652
Liver Cancer 2018 NCI 1R01CA218008-01A1 A Novel Druggable Epigenetic Vulnerability Pathway in HCC GREEN, MICHAEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $599,752
Liver Cancer 2018 NCI 5F30CA213799-02 Role of hedgehog signaling in tumor-associated macrophage polarization PETTY, AMY DUKE UNIVERSITY NC $35,796
Liver Cancer 2018 NCI 5R01CA218486-02 Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation HUSSAIN, SHEHNAZ CEDARS-SINAI MEDICAL CENTER CA $661,266
Liver Cancer 2018 NCI 2R44CA165312-05 Development of a urine test for the early detection of liver cancer JAIN, SURBHI JBS SCIENCE, INC. PA $1,000,000
Liver Cancer 2018 NCI 1R21CA228089-01 Etheno Adducts in Liver Cancer PFEIFER, GERD VAN ANDEL RESEARCH INSTITUTE MI $247,950
Liver Cancer 2018 NCI 1U01CA220477-01A1 gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $518,198
Liver Cancer 2018 NCI 3R01CA190776-04S1 A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $116,456
Liver Cancer 2018 NCI 5K08CA193915-04 The Mechanism of Tumor Formation in Beckwith-Wiedemann Syndrome KALISH, JENNIFER CHILDREN'S HOSP OF PHILADELPHIA PA $140,504
Liver Cancer 2018 NCI 5U01CA185188-04 Analysis of Racial Disparities in HCC by Systems Metabolomics RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $255,915
Liver Cancer 2018 NCI 5K07CA197179-04 Genetic and Environmental Risk of Liver Disease/Cancer among Mexicans FLORES, YVONNE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $160,920
Liver Cancer 2018 NCI 5R01CA200007-04 Multiplexed imaging of biliary intra-epithelial neoplasia SEIBEL, ERIC UNIVERSITY OF WASHINGTON WA $574,722
Liver Cancer 2018 NCI 5R01CA218442-02 Creation of in vivo active chemical probes for CAMKK2 to treat cancer DREWRY, DAVID UNIV OF NORTH CAROLINA CHAPEL HILL NC $649,225
Liver Cancer 2018 NIAID 5R21AI131328-02 AAV2 and hepatocellular carcinoma SRIVASTAVA, ARUN UNIVERSITY OF FLORIDA FL $184,688
Liver Cancer 2018 NCI 5U01CA188387-04 Gut microbiota mediated bile acid alterations in hepatic carcinogenesis JIA, WEI UNIVERSITY OF HAWAII AT MANOA HI $550,892
Liver Cancer 2018 NCI 5F31CA220997-02 Probing the role of a highly expressed lncRNA in hepatocellular carcinoma YU, ALLEN STATE UNIVERSITY NEW YORK STONY BROOK NY $36,064
Liver Cancer 2018 NCI 5R01CA204373-03 Imaging Liver Cancer Proliferation LEE, ZHENGHONG CASE WESTERN RESERVE UNIVERSITY OH $378,195
Liver Cancer 2018 NIBIB 5R21EB023605-02 Exploring combined hyperpolarized 13C MRI with liver-specific gadolinium contrast agents for improved metabolic assessment of liver tumors OHLIGER, MICHAEL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $198,125
Liver Cancer 2018 NIBIB 1R21EB024553-01A1 Motion Compensated 4D Fluoroscopy And Dynamic Roadmaps For Real Time Device Guidance In Minimally Invasive Liver Procedures WAGNER, MARTIN UNIVERSITY OF WISCONSIN-MADISON WI $298,276
Liver Cancer 2018 NCI 5R01CA135069-09 Glycans in Hepatocellular Carcinoma GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY DC $404,488
Liver Cancer 2018 NIDDK 5R01DK111547-02 Regional Cholangiocyte Stress Responses in Biliary Disease PACK, MICHAEL UNIVERSITY OF PENNSYLVANIA PA $402,500
Liver Cancer 2018 NCI 5R01CA062130-23 Role of heat shock transcription factor HSF1 in tumoroginesis MIVECHI, NAHID AUGUSTA UNIVERSITY GA $556,510
Liver Cancer 2018 NCI 2R01CA158439-05A1 Monitoring and control of human liver cancer ablation using real-time, 3D echo decorrelation imaging MAST, T DOUGLAS UNIVERSITY OF CINCINNATI OH $437,316
Liver Cancer 2018 NIAID 5F32AI126660-03 RNA-Protein Interactions During Hepatitis C Virus Infection ADAMS, REBECCA YALE UNIVERSITY CT $61,174
Liver Cancer 2018 NCI 5R01CA212008-02 Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis SINGAL, AMIT UT SOUTHWESTERN MEDICAL CENTER TX $662,072
Liver Cancer 2018 NIDDK 5F32DK111151-03 A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation WALESKY, CHAD BRIGHAM AND WOMEN'S HOSPITAL MA $63,034
Liver Cancer 2018 NCI 5P30CA142543-09 6364 Population Science and Cancer Control Scientific Program WILLSON, JAMES UT SOUTHWESTERN MEDICAL CENTER TX $53,118
Liver Cancer 2018 NCI 1F32CA220972-01A1 Tumor Suppression by an African Specific Variant of p53 BARNOUD, THIBAUT WISTAR INSTITUTE PA $59,038
Liver Cancer 2018 NIDDK 5R01DK105198-03 Metabolic Regulation of Liver Growth GOESSLING, WOLFRAM BRIGHAM AND WOMEN'S HOSPITAL MA $547,130
Liver Cancer 2018 NIDDK 1F30DK117615-01 Neuregulin-4 Signaling in Hepatocytes Defines an Endocrine Checkpoint for NASH and HCC Progression KUANG, HENRY UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $35,867
Liver Cancer 2018 NCI 1F30CA206495-01A1 Bile Acid-Mediated IQGAP1 Regulation Drives Hepatic Tumorigenesis ERICKSON, HANNA UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $45,271
Liver Cancer 2018 NCI 1F32CA228435-01 The Role of the Six Transmembrane Epithelial Antigen of the Prostate 2 in Hepatocellular Carcinoma ZEBALLOS, CARLA UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $64,527
Liver Cancer 2018 NCI 5R01CA172230-05 TREM-1 and Its Implications to Cancer HORUZSKO, ANATOLIJ AUGUSTA UNIVERSITY GA $315,400
Liver Cancer 2018 NCI 5R44CA183265-03 FrostBite - A Unique Catheter for Endoscopic Cryoablation BAUST, J CELL PRESERVATION SERVICES, INC. NY $737,450
Liver Cancer 2018 NIDDK 5R01DK103735-03 Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B COOPER, STEWART CALIFORNIA PACIFIC MED CTR RES INSTITUTE CA $707,841
Liver Cancer 2018 NCATS 5R21TR001743-03 Targeting glucose metabolism for the treatment of Hepatocellular Carcinoma CHEN, BIN MICHIGAN STATE UNIVERSITY MI $267,711
Liver Cancer 2018 NCI 5R01CA197081-03 Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation AHMED, MUNEEB BETH ISRAEL DEACONESS MEDICAL CENTER MA $470,573
Liver Cancer 2018 NCI 1R01CA228414-01 Targeted MEK inhibition to enhance immunotherapy in cholangiocarcinoma LESINSKI, GREGORY EMORY UNIVERSITY GA $391,138
Liver Cancer 2018 NIBIB 1R21EB026324-01 Improving Efficacy of Local Drug Delivery Using Ultrasound EXNER, AGATA CASE WESTERN RESERVE UNIVERSITY OH $189,021
Liver Cancer 2018 NIDDK 5R01DK056621-17 Hepatic autophagy, Stem cells and Fibrosis FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $381,375
Liver Cancer 2018 NIAAA 5R01AA024169-02 Molecular mechanism of alcohol-associated liver tumor development ZHONG, SHUPING UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Liver Cancer 2018 NIAAA 5R01AA025204-02 NANOG-positive cancer stem cells in liver oncogenesis induced by alcohol and HCV MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Liver Cancer 2018 NCI 5R42CA168123-04 In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma GHANDEHARI, HAMID THERATARGET UT $399,441
Liver Cancer 2018 FIC 5U54CA221205-02 6395 Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria ROBERTS, LEWIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $27,006
Liver Cancer 2018 NCI 5U54CA221205-02 6395 Epigenetic Biomarkers of HIV-Associated Hepatocellular Carcinoma in Nigeria ROBERTS, LEWIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $184,866
Liver Cancer 2018 NCI 5U01CA179582-05 The Role of Probiotic Bifidobacteria and Bile Acid Metabolism in Carcinogenesis WAN, YU-JUI UNIVERSITY OF CALIFORNIA AT DAVIS CA $502,118
Liver Cancer 2018 NCI 5R03CA216153-02 Potential Role of the Novel Angiopoietin-like Protein RIFL/Angptl8 in Hepatocellular Carcinoma SMAS, CYNTHIA UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS OH $76,750
Liver Cancer 2018 NIGMS 5R01GM123766-02 Systems Metabolomics for HCC Biomarker Discovery RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $311,000
Liver Cancer 2018 NCI 5P30CA196521-04 7061 Liver Cancer (LC) (Project-003) FRIEDMAN, SCOTT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $10,690
Liver Cancer 2018 NCI 2R44CA192428-02A1 Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation ALLEN, MICHAEL EMBOLX, INC. CA $893,847
Liver Cancer 2018 NCI 1R43CA224642-01A1 Development of Novel Targeted Therapy for Hepatocellular Carcinoma TAPADAR, SUBHASISH SOPHIA BIOSCIENCE, INC. GA $300,000
Liver Cancer 2018 NCI 2R42CA189637-02A1 MDCT Quantification of hepatic tumor viability for assessment of cancer therapy WU, YIN IQ MEDICAL IMAGING, LLC MA $726,042
Liver Cancer 2018 NCI 5R01CA208735-02 (PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity FELSHER, DEAN STANFORD UNIVERSITY CA $730,063
Liver Cancer 2018 NCI 5DP5OD021391-04 Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology GADE, TERENCE UNIVERSITY OF PENNSYLVANIA PA $392,146
Liver Cancer 2018 NIDCR 5DP5OD021391-04 Image-Based Phenotyping of Hepatocellular Carcinoma Cell Survival Under Ischemic Stress: Toward Metabolic Imaging of Cancer Dormancy Using Hyperpolarized Carbon-13 Technology GADE, TERENCE UNIVERSITY OF PENNSYLVANIA PA $1
Liver Cancer 2018 FIC 5U54CA190165-05 7860 Adminstrative and Coordinating Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $8,248
Liver Cancer 2018 NCI 5U54CA190165-05 7860 Adminstrative and Coordinating Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $142,597
Liver Cancer 2018 FIC 5U54CA190165-05 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $11,941
Liver Cancer 2018 NCI 5U54CA190165-05 7861 The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep Carcinoma KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $206,457
Liver Cancer 2018 FIC 5U54CA190165-05 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $14,839
Liver Cancer 2018 NCI 5U54CA190165-05 7862 Pre Malignant Cirrhosis and Hepatocellular Carcinoma in HIV Infected Ugandans KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $256,559
Liver Cancer 2018 FIC 5U54CA190165-05 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $8,906
Liver Cancer 2018 NCI 5U54CA190165-05 7863 Biomarker and Analytical Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $153,975
Liver Cancer 2018 FIC 5U54CA190165-05 7874 Developmental Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $6,067
Liver Cancer 2018 NCI 5U54CA190165-05 7874 Developmental Core KIRK, GREGORY JOHNS HOPKINS UNIVERSITY MD $104,895
Liver Cancer 2018 NCI 5F99CA222741-02 Metabolic rewiring regulates cancer growth and tumor-associated immune responses ZHAO, STEVEN UNIVERSITY OF PENNSYLVANIA PA $31,589
Liver Cancer 2018 NCI 5R01CA215520-02 CONTRAST-ENHANCED ULTRASOUND EVALUATION OF FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSIS OR OTHER RISK FACTORS FOR DEVELOPING HCC LYSHCHIK, ANDREJ THOMAS JEFFERSON UNIVERSITY PA $606,361
Liver Cancer 2018 NIDDK 5R01DK110024-02 Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis ROBERTSON, KEITH MAYO CLINIC ROCHESTER MN $601,776
Liver Cancer 2018 NIGMS 5P20GM113126-03 5964 Quantifying Biochemical Communication in Hepatocellular Carcinoma STAINS, CLIFF UNIVERSITY OF NEBRASKA LINCOLN NE $143,253
Liver Cancer 2018 NCATS 5UH2TR002087-02 Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma ZARRINPAR, ALI UNIVERSITY OF FLORIDA FL $269,386
Liver Cancer 2018 NCI 1R56CA229262-01 Genome targeting of liver cancer LUO, JIANHUA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $357,994
Liver Cancer 2018 NCI 1R37CA230636-01 Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma LUJAMBIO, AMAIA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $387,731
Liver Cancer 2018 NIDDK 1K23DK118200-01 Improving the Diagnosis of Liver Disease in Primary Care Patients with Abnormal Liver Function SCHREINER, ANDREW MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $174,108
Liver Cancer 2018 NCI 1R21CA229927-01 A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCC WAJAPEYEE, NARENDRA YALE UNIVERSITY CT $218,588
Liver Cancer 2018 NIAID 1R21AI139954-01 Impact of Occult Hepatitis C Virus Infection in Progression of Liver Diseases SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $288,750
Liver Cancer 2018 NCI 1R21CA230098-01 Targeting of TCF4 PARylation in the vascular niche to obliterate chemoresistant hepatocarcinoma cells CAO, ZHONGWEI ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $221,198
Liver Cancer 2018 NCI 1U24CA230144-01 Consortium on Translational Research in Early Detection of Liver Cancer: Data Management and Coordinating Center (DMCC) FENG, ZIDING FRED HUTCHINSON CANCER RESEARCH CENTER WA $567,201
Liver Cancer 2018 NCI 1U01CA230669-01 NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION LOK, ANNA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $664,962
Liver Cancer 2018 NCI 1U01CA230690-01 Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer MISHRA, LOPA GEORGE WASHINGTON UNIVERSITY DC $710,451
Liver Cancer 2018 NCI 1U01CA230694-01 Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States SINGAL, AMIT UT SOUTHWESTERN MEDICAL CENTER TX $753,176
Liver Cancer 2018 NCI 1U01CA230705-01 The UCLA Center in Early Detection of Liver Cancer ZHOU, XIANGHONG UNIVERSITY OF CALIFORNIA LOS ANGELES CA $685,284
Liver Cancer 2018 NCI 1R01CA230848-01 (PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis FU, LONING BAYLOR COLLEGE OF MEDICINE TX $442,560
Liver Cancer 2018 NCI 1U01CA230997-01 Risk Stratification for and Early Detection of Liver Cancer KANWAL, FASIHA BAYLOR COLLEGE OF MEDICINE TX $732,726
Liver Cancer 2018 NCI 1R01CA219541-01A1 Epigenetic Mechanisms of Biliary Epithelial Neoplasia WU, TONG TULANE UNIVERSITY OF LOUISIANA LA $344,269
Liver Cancer 2018 NCI 1R01CA221916-01A1 Role of protein mediate fatty acid uptake in liver cancer STAHL, ANDREAS UNIVERSITY OF CALIFORNIA BERKELEY CA $527,212
Liver Cancer 2018 NIDDK 1R01DK115461-01A1 Therapeutic pathway reprogramming for metabolic liver disease BISSIG, KARL-DIMITER BAYLOR COLLEGE OF MEDICINE TX $356,625
Liver Cancer 2018 NCI 3R01CA186566-04S1 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $165,134
Liver Cancer 2018 NCI 3R01CA201127-03S1 Simultaneous Thermal and Osmotic Stresses in Tumor Ablation: Imaging and Biology CRESSMAN, ERIK UNIVERSITY OF TX MD ANDERSON CAN CTR TX $220,798
Liver Cancer 2018 NCI 3U01CA185188-04S1 Analysis of Racial Disparities in HCC by Systems Metabolomics RESSOM, HABTOM GEORGETOWN UNIVERSITY DC $67,546
Liver Cancer 2018 NCI 1K08CA222676-01A1 Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC) DHANASEKARAN, RENUMATHY STANFORD UNIVERSITY CA $202,144
Liver Cancer 2018 NCI 3R01CA184456-03S2 VDAC Regulation of Warburg Metabolism in Hepatocarcinoma MALDONADO, EDUARDO MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $65,611
Liver Cancer 2018 NIBIB 1R21EB024677-01A1 Development of motion-corrected 4D digital subtraction angiography and quantification of embolization related changes in hepatic arterial blood flow LAESEKE, PAUL UNIVERSITY OF WISCONSIN-MADISON WI $184,890
Liver Cancer 2018 NCI 1R01CA221971-01A1 Optimization and Evaluation of Anatomical Models of Liver Radiation Response BROCK, KRISTY UNIVERSITY OF TX MD ANDERSON CAN CTR TX $362,432
Liver Cancer 2018 NCI 1R21CA232258-01 Exploring immune surveillance in isocitrate dehydrogenase mutant cholangiocarcinoma SAHA, SUPRIYA FRED HUTCHINSON CANCER RESEARCH CENTER WA $218,970
Liver Cancer 2018 NIBIB 1R01EB026207-01A1 Image-Guided Transcatheter Delivery of Natural Killer Cell Therapy Augmented with IFN-Gamma Eluting Microspheres KIM, DONG-HYUN NORTHWESTERN UNIVERSITY AT CHICAGO IL $347,040
Liver Cancer 2018 NCI 1F30CA232388-01 Molecular imaging meets big data: a systems-level approach for application-driven, unbiased selection of metabolic imaging substrates for visualization of cancer dormancy PERKONS, NICHOLAS UNIVERSITY OF PENNSYLVANIA PA $49,524
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer